Xspray Pharma AB (publ) (XSPRAY.ST)
Develops improved cancer drugs using microparticle technology to treat leukemia and solid tumors.
16.72+0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-66.1%
The outlook
Xspray trades well below both its 50- and 200-day moving averages and sits near its 52-week low, reflecting weak near-term momentum. Analyst targets average 259% above the current price, though coverage appears sparse. The overall lean is bearish despite the distant price targets.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Price targetAvg target +259% vs current price
Market cap
$792.8M
52-wk high
64.10
52-wk low
14.16
50-day avg
17.72
200-day avg
24.77
Trailing P/E
—